Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,857
archived clinical trials in
Hot Flash

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1173
mi
from
Valley Village, CA
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1173
mi
from
Valley Village, CA
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
801
mi
from
Atlanta, GA
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1050
mi
from
Meridian, ID
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1050
mi
from
Meridian, ID
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1142
mi
from
Elkridge, MD
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1142
mi
from
Elkridge, MD
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
843
mi
from
Kingsport, TN
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
843
mi
from
Kingsport, TN
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
569
mi
from
Houston, TX
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
569
mi
from
Houston, TX
Click here to add this to my saved trials
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
779
mi
from
Riverton, UT
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)
A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
779
mi
from
Riverton, UT
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
853
mi
from
Phoenix, AZ
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
853
mi
from
Phoenix, AZ
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1102
mi
from
Clearwater, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1102
mi
from
Clearwater, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1271
mi
from
Jupiter, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1271
mi
from
Jupiter, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
198
mi
from
Kansas City, MO
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
198
mi
from
Kansas City, MO
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
567
mi
from
Schertz, TX
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
567
mi
from
Schertz, TX
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
683
mi
from
Birmingham, AL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1163
mi
from
Norwalk, CA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1163
mi
from
Norwalk, CA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
409
mi
from
Denver, CO
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
409
mi
from
Denver, CO
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1314
mi
from
Hialeah, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1314
mi
from
Hialeah, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1320
mi
from
Miami, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1320
mi
from
Miami, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1244
mi
from
Port Saint Lucie, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1244
mi
from
Port Saint Lucie, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1143
mi
from
Sarasota, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1143
mi
from
Sarasota, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
843
mi
from
Idaho Falls, ID
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
843
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
971
mi
from
Las Vegas, NV
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
971
mi
from
Las Vegas, NV
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1248
mi
from
LawrenceVille, NJ
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1248
mi
from
LawrenceVille, NJ
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1225
mi
from
Philadelphia, PA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
518
mi
from
Jackson, TN
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
518
mi
from
Jackson, TN
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
788
mi
from
Ogden, UT
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
788
mi
from
Ogden, UT
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
779
mi
from
Salt Lake City, UT
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1053
mi
from
Jacksonville, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1053
mi
from
Jacksonville, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1091
mi
from
Ponte Vedra, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1091
mi
from
Ponte Vedra, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1284
mi
from
West Palm Beach, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1284
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
27
mi
from
Wichita, KA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
27
mi
from
Wichita, KA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
864
mi
from
Bristol, TN
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
864
mi
from
Bristol, TN
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
467
mi
from
Memphis, TN
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
467
mi
from
Memphis, TN
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
346
mi
from
Fort Worth, TX
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
346
mi
from
Fort Worth, TX
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
838
mi
from
Dothan, AL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
838
mi
from
Dothan, AL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
797
mi
from
Sandy Springs, GA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
797
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
810
mi
from
Columbus, OH
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
810
mi
from
Columbus, OH
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
775
mi
from
Draper, UT
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
775
mi
from
Draper, UT
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1069
mi
from
Crystal River, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1069
mi
from
Crystal River, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1189
mi
from
Morehead City, NC
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1189
mi
from
Morehead City, NC
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1181
mi
from
Norfolk, VA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1181
mi
from
Norfolk, VA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1387
mi
from
New London, CT
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1387
mi
from
New London, CT
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
690
mi
from
Metairie, LA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
690
mi
from
Metairie, LA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1148
mi
from
Baltimore, MD
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
721
mi
from
Kalamazoo, MI
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
721
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
826
mi
from
Saginaw, MI
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
826
mi
from
Saginaw, MI
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1143
mi
from
San Diego, CA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1139
mi
from
Orlando, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1139
mi
from
Orlando, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1277
mi
from
Wellington, FL
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1277
mi
from
Wellington, FL
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
699
mi
from
Marrero, LA
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
699
mi
from
Marrero, LA
Click here to add this to my saved trials
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
976
mi
from
Winston-Salem, NC
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
A Randomized, Double Blind, Placebo Controlled Study to Assess the Effect of MT-8554 on the Frequency and Severity of Vasomotor Symptoms in Postmenopausal Women
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
976
mi
from
Winston-Salem, NC
Click here to add this to my saved trials